FDA Grants Clearance to Luminex for Molecular Test
Luminex has received FDA clearance for the Aries Flu A/B & RSV assay.
The molecular testing device delivers results in less than two hours for the detection and differentiation of influenza A virus, influenza B virus, and respiratory syncytial virus, the company stated.
This is the second assay the FDA has cleared for use on the Luminex Aries system. — Cynthia Jessup